Morgan Stanley stock heads into Monday after a 2.3% jump — here’s what traders watch next
8 February 2026
1 min read

Morgan Stanley stock heads into Monday after a 2.3% jump — here’s what traders watch next

New York, Feb 8, 2026, 14:26 (ET) — The market has wrapped up for the day.

  • Morgan Stanley climbed 2.3% Friday, ending its three-day slide.
  • Wall Street’s strong rally pushed the Dow past 50,000 at the close, marking its first finish above that level.
  • Coming up for investors: delayed U.S. jobs and inflation numbers land Friday. Morgan Stanley, meanwhile, won’t report results until April.

Morgan Stanley’s stock settled at $179.96 Friday, up 2.3%. Shares moved within a $175.52 to $181.17 band during the session. The last open was $178.89.

U.S. markets being closed on Sunday leaves investors heading into Monday’s open with that move top of mind. Unclear for now: was Friday’s bounce just a quick relief rally, or the first sign of a more sustained push into large financial stocks?

Morgan Stanley depends heavily on lively markets and investor confidence. Trading, dealmaking, and the wealth management division’s client assets all swing with those forces. If investors shift gears, the bank tends to notice in short order.

The rally Friday swept across the board. Dow Jones Industrial Average topped 50,000 for the first time ever, with investors shifting money out of crowded tech and AI trades after a rough stretch for several software stocks. “What’s driven it recently has been the broadening that we have seen in the market,” said Chuck Carlson, chief executive officer at Horizon Investment Services. (Reuters)

Morgan Stanley’s advance trailed rivals. JPMorgan Chase jumped 3.95% for the day, Wells Fargo picked up 2.63%, and Charles Schwab added 3.02%. Still, Morgan Stanley’s shares remain roughly 6.6% off their recent 52-week high, MarketWatch data show. (MarketWatch)

Bank stock traders watch bond yields closely — a quick read on where rates might be headed. When rate expectations drop, risk assets and dealmaking often get a lift. On the flip side, that same move can pinch net interest income, narrowing the gap between what banks earn from loans and what they pay out for funding.

Friday’s run could stall if upcoming U.S. data stirs up inflation concerns again. Stronger-than-expected inflation would likely send yields up, threatening the “soft landing” narrative that fueled last week’s rally.

Morgan Stanley set its Q1 2026 investor call for April 15, with earnings set to drop around 7:30 a.m. ET that morning, according to a previous statement from the bank. (Morgan Stanley)

First up, Friday brings the next major catalyst. With the government’s disrupted economic calendar, core data points are now stacked, and the Bureau of Labor Statistics lists the postponed January jobs report and the January CPI as both landing at 8:30 a.m. ET on Feb. 13. That double release has the potential to jolt yields, spark shifts in rate-cut bets, and send bank stocks moving fast. (bls.gov)

Stock Market Today

  • Netskope (NTSK) Share Price Slump: Is the Stock Overvalued Despite Recent Declines?
    February 8, 2026, 5:12 PM EST. Netskope's share price fell 19.1% in the past week, 27.8% in 30 days, and is down 28.9% year to date. Despite the decline, a Discounted Cash Flow (DCF) analysis shows the stock is trading at a 71.3% premium over its estimated intrinsic value of $7.01 per share, suggesting overvaluation. The company scores just 1 out of 6 on valuation checks, indicating potential risk. Netskope operates in cybersecurity and cloud software, sectors sensitive to growth and profitability expectations. Investors should consider these factors amid shifting risk sentiment and fluctuating investor confidence.

Latest article

Amgen stock jumps to a 52-week high; here’s what to watch before Monday’s open

Amgen stock jumps to a 52-week high; here’s what to watch before Monday’s open

8 February 2026
Amgen shares jumped 4.49% to $384.32 Friday, hitting a 52-week high as the Dow closed above 50,000 for the first time. The move followed strong quarterly results and a $2.52 per share dividend declaration. CVS Caremark will drop Amgen’s Prolia from some preferred lists in April, citing biosimilar competition. Investors await next week’s delayed U.S. jobs and inflation data.

Popular

Novartis share price sits near a 52-week high after San Diego research build — what investors watch next
Previous Story

Novartis share price sits near a 52-week high after San Diego research build — what investors watch next

Wells Fargo stock price jumps Friday — what to watch before Monday’s open
Next Story

Wells Fargo stock price jumps Friday — what to watch before Monday’s open

Go toTop